The GLP-1 receptor agonists are successful in the treatment of type-2 diabetes and the treatment of obesity, with a variety of additional benefits currently being explored
Nausea Management The following prescriber framework for managing retatrutide-associated nausea is based on the dose-escalation designs used across GLP-1/GIP/GCGR phase 2 studies and analogous protocols from the tirzepatide prescribing information (PI)
OBGYN specialists are qualified to evaluate whether this medication is appropriate and may recommend it when weight affects hormone balance, fertility, or long-term health
Resistance may arise from ESR1 mutations or alternative growth pathways
References: Sinha, R., Sinha, I., Calcagnotto, A., Trushin, N., Haley, J
The work presented here, published in the journal Biomedicine s, builds a bridge between laboratory bench and bedside by showing proof-of-concept that supplementing people with HIV specifically with a combination of glycine and N-acetylcysteine, which we call GlyNAC, as precursors of glutathione, a major antioxidant produced by the body, improves multiple deficits associated with premature aging, said Sekhar
